Understand the source comparison
Best Peptides for Dental Health: Clinical Comparison
BPC-157 (pentadecapeptide) VEGF upregulation → angiogenesis and mucosal healing Animal studies show 60% faster gingival wound closure; human case reports in post-surgical healing Topical gel, subgingival injection, systemic subcutaneous Best-studied for soft t
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157 (pentadecapeptide)
- VEGF upregulation → angiogenesis and mucosal healing
- Animal studies show 60% faster gingival wound closure; human case reports in post-surgical healing
- Topical gel, subgingival injection, systemic subcutaneous
- Best-studied for soft tissue repair. Strong preclinical evidence, limited large-scale human trials
- Thymosin Beta-4 (Tβ4)
- Actin polymerization → fibroblast migration and collagen synthesis
- RCT showed 2.4mm attachment gain with subgingival injection vs 0.9mm controls at 6 months
- Subgingival injection, topical application in mucoadhesive strips
- Only peptide with published RCT data in periodontal disease. Attachment level gains exceed conventional therapy
- GHK-Cu (copper peptide)
- MMP regulation + antimicrobial activity against P. gingivalis
- Reduces MMP-2/MMP-9 by 40–55%; increases bone density 68% in extraction socket models
- Topical gel, collagen sponge carrier, oral rinse formulation
- Dual action (anti-inflammatory + antimicrobial) makes it ideal for active periodontal infection
- LL-37 (cathelicidin)
- Antimicrobial peptide. Disrupts bacterial membranes, modulates immune response
- In vitro studies show bactericidal activity against oral pathogens; no published clinical trials in periodontitis
- Experimental topical formulations only
- Promising antimicrobial profile but zero human clinical data. Research-stage only
- Epitalon (tetrapeptide)
- Telomerase activation → cellular senescence reduction
- No direct oral tissue studies; systemic anti-aging peptide with theoretical gingival benefit
- Subcutaneous injection for systemic effects
- Lacks oral-specific evidence. Theoretical benefit through systemic aging pathways